Platelet-tolymphocyte ratio in patients with metastatic breast cancer treated with eribulin

被引：0
|
作者：
Shimada, Hiroko
Matsuura, Kazuo
Kohyama, Shunsuke
Asano, Aya
Ohara, Masahiro
Ishiguro, Hiroshi
Osaki, Akihiko
Saeki, Toshiaki
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO2-15-03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO2-15-03
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Metronomic eribulin in metastatic breast cancer
    Chalasani, Pavani
    Robert, Livingston B.
    Rado, Thomas A.
    Gadi, Vijayakrishna K.
    Kummet, Thomas D.
    Specht, Jennifer M.
    Stopeck, Alison
    Linden, Hannah M.
    CANCER RESEARCH, 2015, 75
  • [22] Efficacy and toxicity of eribulin treatment in metastatic breast cancer patients
    Brems-Eskildsen, Anne Sofie
    Kristoffersen, Kristina Bak
    Linnet, Soren
    Lorincz, Tamas
    Langkjer, Sven Tyge
    ACTA ONCOLOGICA, 2019, 58 (01) : 119 - 121
  • [23] Efficacy, safety and cost of eribulin in patients with metastatic breast cancer
    Paillard, Marie-Justine
    Curtit, Elsa
    Dobi, Erion
    Mansi, Laura
    Bazan, Fernando
    Villanueva, Cristian
    Chaigneau, Loic
    Montcuquet, Philippe
    Meneveau, Nathalie
    Thiery-Vuillemin, Antoine
    Nerich, Virginie
    Pivot, Xavier
    BULLETIN DU CANCER, 2015, 102 (09) : 737 - 748
  • [24] Safety of eribulin in Korean patients with metastatic breast cancer.
    Park, Yeon Hee
    Im, Young-Hyuck
    Lee, Keun-Seok
    Park, In Hae
    Sohn, Joohyuk
    Lee, Soohyeon
    Kim, Tae Yong
    Im, Seock-Ah
    Kim, Jee Hyun
    Kim, Se Hyun
    Lee, Soo Jung
    Koh, Su-Jin
    Lee, Ki Hyeong
    Choi, Yoon Ji
    Cho, Eun Kyung
    Lee, Suee
    Kang, Seok Yun
    Seo, Jae Hong
    Kim, Sung-Bae
    Jung, Kyung Hae
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [25] Eribulin Suppresses New Metastases in Patients With Metastatic Breast Cancer
    Fujii, Takaaki
    Tokuda, Shoko
    Nakazawa, Yuko
    Kurozumi, Sasagu
    Obayashi, Sayaka
    Yajima, Reina
    Shirabe, Ken
    IN VIVO, 2020, 34 (02): : 917 - 921
  • [26] Peripheral neuropathy (PN) in patients (pts) with metastatic breast cancer treated with eribulin: Resolution and association with efficacy
    Kaufman, Peter
    Olivo, Martin
    He, Yi
    McCutcheon, Susan
    Vandat, Linda
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (26)
  • [27] A retrospective safety and efficacy analysis of the first patients treated with eribulin for metastatic breast cancer in Stockholm, Sweden
    Kessler, Luisa
    Falato, Claudette
    Margolin, Sara
    Bergh, Jonas
    Foukakis, Theodoros
    ACTA ONCOLOGICA, 2015, 54 (04) : 522 - 529
  • [28] Clinical outcomes of patients with metastatic breast cancer treated with eribulin: A realworld evidence study from China
    Yan, Xi
    Chen, Lan
    He, Ping
    Tian, Ting-Lun
    Zhong, Xiaorong
    Luo, Ting
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [29] Interleukin-6 and C-Reactive protein in metastatic breast cancer patients treated with eribulin
    Kadri Altundag
    Breast Cancer Research and Treatment, 2024, 203 : 627 - 627
  • [30] Effect of age on tolerability and efficacy of eribulin and capecitabine in patients with metastatic breast cancer treated in study 301
    Kaufman, P. A.
    Yelle, L.
    Cortes, J.
    Perez, E. A.
    Awada, A.
    Wanders, J.
    Olivo, M. S.
    Dutcus, C. E.
    Twelves, C.
    CANCER RESEARCH, 2013, 73
12345